Chat
+91 9041725050
9.30 am - 5.30 pm Mon to Sat
Request Callback
  • Login
  • Sign up
    • Home
      • About Us
      • Company Profile
    • Events
      • Cinnamon Seminar
      • CPEIS-2026
      • Flow Chemistry India 2026 (FCI26)
      • Past Events
    • Event Sciences
      • Conference Management
      • Physical Events
      • Virtual Events
      • Tech. Exhibitions
      • Networking
      • Sponsorship
      • Oral/Poster Presentation
    • Resources
      • Blogs
    • Gallery
    • Contact Us

    PharmaAQ Expert Forum – Analytical Method – Qualification, Validation & Transfer

    Overview

    PharmaAQ (Pharma Analysis and Quality) Expert Forum is a technical discussion group comprising of Senior Team Leaders and/or R & D Heads. The forum envisages bringing together both the Pharma and CRO companies at a single platform to discuss the hottest issues and topics for achieving research and business objectives.

    The US Food and Drug Administration (US FDA) guidance on process validation describes three stages viz. process design, process performance qualification, and process performance verification. For an analytical method, a method procedure must be monitored efficiently. Before an analytical method can be validated, it is required to define the method development goals and its acceptance criteria usually referred to as analytical target profile. The analytical method development for quality control follows GMP and QbD principles and must be validated for its specificity, accuracy, precision, linearity, range LOD and LOQ etc. Analytical methods are developed using strict validation protocols. The USP states that the transfer of an analytical method is the documented process that qualifies a laboratory (receiving laboratory) to use an analytical method that originated in another laboratory (transferring laboratory), whether that is internal or external to the receiving laboratory.

    This discussion forum will be held on November 18, 2021, virtually and is brought to you by the organizing team of Pharma Analysis and Quality conferences in Mumbai on 11-12 October 2018 and Round-table meetings on Nitrosamine Impurities in December 2019 and February 2020. This forum will deliberate upon the various practical aspects of the analytical method pre-validation or qualification, validation, verification and transfer, challenges in developing a robust method, regulatory compliance for analytical methods as well as other issues related to analytical method development and validation.

    The H2L Concept- The H2L or Honing to Lead is a novel concept and means honing or refining skills of the team leaders who have the responsibility to steer their team towards achieving the organizational goals. The H2L concept is about refining specifically the technical skills of the team leaders through higher level experts who have vast first-hand experience in the respective areas so that the leader gets an extremely focused conceptual insight into the problem area. This essentially involves bringing together the leaders who share a common platform with the Experts and where the Experts develop an atmosphere conducive to open discussion rather than a regular speaking-listening session.

    Who Should Attend

    Heads, Vice Presidents, Directors, Senior Managers, Team Leaders, Senior Scientists from Pharma and CRO Organizations working in various domains: Analytical Method Development, Quality control, Formulation Development, Regulatory Affairs, Quality Assurance, Data management/data integrity, and Pharma R&D.

    Contacts

    Technical Query: Ms. Pooja Sharma, M: 7696325050, Email: p.sharma@glostem.com
    Participation Query: Ms. Swati Kanwar, M: 8289015050, Email: s.kanwar@glostem.com
    Registration Support: Ms. Ankita Kanwar, M: 7696425050, Email: ankita@glostem.com

    Conference Date

    18-11-2021

    Saranjit Singh
    Saranjit Singh
    Professor & Head - NIPER Mohali
    Stephan O. Krause
    Stephan O. Krause
    Head of Product Quality Group - AstraZeneca Biologics, USA
    Gautam Samanta
    Gautam Samanta
    Vice President - Quality by Design and Process Scale-up - Cipla Ltd
    Trupti Tol
    Trupti Tol
    Associate Director - Cipla Ltd
    Chait Wannere
    Chait Wannere
    Senior Director, Analytical Development - TCG GreenChem, USA
    Bhaskar Kolte
    Bhaskar Kolte
    Associate Director -ARD - Perrigo Laboratories India Pvt Ltd

    Saranjit Singh's Biography

    Saranjit Singh

    Professor & Head

    NIPER Mohali


    Stephan O. Krause's Biography

    Stephan O. Krause

    Head of Product Quality Group

    AstraZeneca Biologics

    Dr Stephan Krause, PhD, is currently Quality Director and PQL Team Leader in Development Quality, AstraZeneca Biologics. He is a results-driven leader with 20 years of technical, managerial, and executive experiences for quality and technical functions within global operations. He is a frequent conference presenter and author and has won multiple industry awards for his publications and leadership in improving industry best practices. Stephan was invited by FDA several times to present an industry perspective to the agency on relevant current topics. He is a member of PDA’s Board of Directors and is co-chair of AMTP Advisory Board and a member of the Advisory Board for Biopharmaceuticals and Regulatory Affairs/Quality.


    Gautam Samanta's Biography

    Gautam Samanta

    Vice President - Quality by Design and Process Scale-up

    Cipla Ltd

    Dr. Gautam Samanta is Sr. Director and Head of Quality by Design and process scale-up department at Cipla Ltd. Previously, he worked at Dr. Reddy’s Laboratories in API development and implemented QbD and PAT in product development. His areas of focus are in-house development of automated systems, Design of Experiments (DOE) and Quality by Design (QBD) including PAT in Pharmaceutical sciences. He was awarded Ph.D. degree from Jadavpur University, Calcutta. Following his Ph.D. degree, he pursued research as a postdoctoral research fellow at the National Institute of Health Sciences, Japan and then the Texas Tech University, USA. After his postdoctoral research, he joined as a research Assistant Professor at the University of Houston, Texas, USA. He has published more than 50 papers in peer-reviewed international journals including the very prestigious Nature. His work has been cited by more than 1500 researchers. He has also authored 5 book chapters. He is an inventor of three process patents. He is a reviewer of many scientific journals such as Analytical Chemistry, Environmental Science and Technology etc. and also a member of many scientific organizations/committees.


    Trupti Tol's Biography

    Trupti Tol

    Associate Director

    Cipla Ltd

    Ms Trupti, an Associate Director, leads a dynamic analytical QbD team at Cipla Pharmaceuticals. She has a rich 15 years’ experience in various analytical techniques such as liquid chromatography, Gas chromatography and Particle size analysis. Ms Trupti was instrumental in implementing QbD across the analytical domain at Cipla. She has published her innovative works in different journals including “Journal of Chromatography A”. Ms Trupti has presented her work as a speaker in many National and International conferences held in India and abroad. She has a master’s degree in Organic Chemistry for the University of Mumbai and is also certified Six Sigma Black Belt.


    Chait Wannere's Biography

    Chait Wannere

    Senior Director, Analytical Development

    TCG GreenChem

    Dr Chait Wannere, Senior Director, Analytical Development, TCG GreenChem, USA.  He is High energy scientific and managerial leader with 15 years of experience in the pharmaceutical industry with  broad knowledge and direct involvement in drug development processes. Extensive knowledge of cGMP activities. Involved with CMC filings of several  products in US and ROW.

    • Instrumental in delivering billion-dollar drugs in an accelerated manner to the market while working at Forest Research Institute and Merck Research Laboratories (MSD in Europe).
    • Thorough knowledge and first-hand experience of global regulatory requirements (US, Europe and ROW), analytical development, validations, QC, Extractables/Leachables, and pre-formulation activities (polymorphism and salt-screening).
    • Skilled at characterization of drug products, RSMs, reactive intermediates, and drug substances (small molecules and peptides). Experienced in development of analytical techniques for analyzing SODs, ODTs, semisolids, suspensions, and sterile injectables and vaccines.
    • Results driven, strategic, and structured professional with proficiency in planning and leading early and late phase projects.
    • 2019:Supported analytical, formulation, and CMC in approval of Flunixin Injectable reformulation for Europe.
    • 2018: Received the Innovation award at Merck for the expansion of lifecycle management of the Fluralaner franchise to include Bravecto 1 Month.
    • 2008-2015: Supported 7 Forest products (including, Linzess, Vraylar, Savella, and Fetzima) at various development stages, including lifecycle stages, and was analytical lead on 4 Merck products (Bravecto 1 Month, Flunixin Injectable, Fluralaner for Cattle, and MOF).
    • About 40 publications: including internationally top scientific journals, reviews and book chapter, H-index of 25 and RG Score of 33.4
    • Served as Reviewer for Journal of Physical Chemistry, Chemical Reviews, and Journal of Organic Chemistry
    • Member of IQ team for Lean Stability and Risk Based Stability approach.

    Bhaskar Kolte's Biography

    Bhaskar Kolte

    Associate Director -ARD

    Perrigo Laboratories India Pvt Ltd


    Conference Agenda

    • Analytical Method Development-Critical Review
    • Analytical Method Qualification and Validation
    • Method Validation Protocols
    • Analytical Method Transfer-Best Practices

    Agenda Topics for Analytical Method – Qualification, Validation & Transfer

    • Analytical Method Development-Critical Review
      • Analytical target profile, Regulatory guidance, and challenges
    • Analytical Method Qualification and Validation
      • Instrument and reagent qualification, Method robustness and verification
    • Method Validation Protocols
      • Protocol characteristics, Acceptance criteria, Handling deviations
    • Analytical Method Transfer-Best Practices
      • Transfer method critical concerns, site evaluation, transfer reports

    Upcoming Conferences

    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    23 - 24 Apr, 2026

    Cinnamon Seminar

    Details
    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    14 - 15 May, 2026

    CPEIS-2026

    Details
    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    10 - 11 Sep, 2026

    Flow Chemistry India 2026 (FCI26)

    Details

    Speakers & Panelists

    Saranjit Singh

    Saranjit Singh's Biography

    Saranjit Singh

    Professor & Head

    NIPER Mohali


    Professor & Head,  NIPER Mohali,

    Stephan O. Krause

    Stephan O. Krause's Biography

    Stephan O. Krause

    Head of Product Quality Group

    AstraZeneca Biologics

    Dr Stephan Krause, PhD, is currently Quality Director and PQL Team Leader in Development Quality, AstraZeneca Biologics. He is a results-driven leader with 20 years of technical, managerial, and executive experiences for quality and technical functions within global operations. He is a frequent conference presenter and author and has won multiple industry awards for his publications and leadership in improving industry best practices. Stephan was invited by FDA several times to present an industry perspective to the agency on relevant current topics. He is a member of PDA’s Board of Directors and is co-chair of AMTP Advisory Board and a member of the Advisory Board for Biopharmaceuticals and Regulatory Affairs/Quality.


    Head of Product Quality Group,  AstraZeneca Biologics,
    USA

    Gautam Samanta

    Gautam Samanta's Biography

    Gautam Samanta

    Vice President - Quality by Design and Process Scale-up

    Cipla Ltd

    Dr. Gautam Samanta is Sr. Director and Head of Quality by Design and process scale-up department at Cipla Ltd. Previously, he worked at Dr. Reddy’s Laboratories in API development and implemented QbD and PAT in product development. His areas of focus are in-house development of automated systems, Design of Experiments (DOE) and Quality by Design (QBD) including PAT in Pharmaceutical sciences. He was awarded Ph.D. degree from Jadavpur University, Calcutta. Following his Ph.D. degree, he pursued research as a postdoctoral research fellow at the National Institute of Health Sciences, Japan and then the Texas Tech University, USA. After his postdoctoral research, he joined as a research Assistant Professor at the University of Houston, Texas, USA. He has published more than 50 papers in peer-reviewed international journals including the very prestigious Nature. His work has been cited by more than 1500 researchers. He has also authored 5 book chapters. He is an inventor of three process patents. He is a reviewer of many scientific journals such as Analytical Chemistry, Environmental Science and Technology etc. and also a member of many scientific organizations/committees.


    Vice President - Quality by Design and Process Scale-up,  Cipla Ltd,

    Trupti Tol

    Trupti Tol's Biography

    Trupti Tol

    Associate Director

    Cipla Ltd

    Ms Trupti, an Associate Director, leads a dynamic analytical QbD team at Cipla Pharmaceuticals. She has a rich 15 years’ experience in various analytical techniques such as liquid chromatography, Gas chromatography and Particle size analysis. Ms Trupti was instrumental in implementing QbD across the analytical domain at Cipla. She has published her innovative works in different journals including “Journal of Chromatography A”. Ms Trupti has presented her work as a speaker in many National and International conferences held in India and abroad. She has a master’s degree in Organic Chemistry for the University of Mumbai and is also certified Six Sigma Black Belt.


    Associate Director,  Cipla Ltd,

    Chait Wannere

    Chait Wannere's Biography

    Chait Wannere

    Senior Director, Analytical Development

    TCG GreenChem

    Dr Chait Wannere, Senior Director, Analytical Development, TCG GreenChem, USA.  He is High energy scientific and managerial leader with 15 years of experience in the pharmaceutical industry with  broad knowledge and direct involvement in drug development processes. Extensive knowledge of cGMP activities. Involved with CMC filings of several  products in US and ROW.

    • Instrumental in delivering billion-dollar drugs in an accelerated manner to the market while working at Forest Research Institute and Merck Research Laboratories (MSD in Europe).
    • Thorough knowledge and first-hand experience of global regulatory requirements (US, Europe and ROW), analytical development, validations, QC, Extractables/Leachables, and pre-formulation activities (polymorphism and salt-screening).
    • Skilled at characterization of drug products, RSMs, reactive intermediates, and drug substances (small molecules and peptides). Experienced in development of analytical techniques for analyzing SODs, ODTs, semisolids, suspensions, and sterile injectables and vaccines.
    • Results driven, strategic, and structured professional with proficiency in planning and leading early and late phase projects.
    • 2019:Supported analytical, formulation, and CMC in approval of Flunixin Injectable reformulation for Europe.
    • 2018: Received the Innovation award at Merck for the expansion of lifecycle management of the Fluralaner franchise to include Bravecto 1 Month.
    • 2008-2015: Supported 7 Forest products (including, Linzess, Vraylar, Savella, and Fetzima) at various development stages, including lifecycle stages, and was analytical lead on 4 Merck products (Bravecto 1 Month, Flunixin Injectable, Fluralaner for Cattle, and MOF).
    • About 40 publications: including internationally top scientific journals, reviews and book chapter, H-index of 25 and RG Score of 33.4
    • Served as Reviewer for Journal of Physical Chemistry, Chemical Reviews, and Journal of Organic Chemistry
    • Member of IQ team for Lean Stability and Risk Based Stability approach.

    Senior Director, Analytical Development,  TCG GreenChem,
    USA

    Bhaskar Kolte

    Bhaskar Kolte's Biography

    Bhaskar Kolte

    Associate Director -ARD

    Perrigo Laboratories India Pvt Ltd


    Associate Director -ARD,  Perrigo Laboratories India Pvt Ltd,

    Analytical Method – Qualification, Validation & Transfer

    Download Programme PDF
    Thursday, 18th November 2021
    13:30
    Test Run and Web Checks
    14:30

    Welcome Address and Introduction to the Experts

    Sanjay Bajaj,  CEO & MD,  Glostem Private Limited,  India

    14:50

    Select Emerging Requirements w.r.t Method Validation

    Saranjit Singh,  Professor & Head,  NIPER Mohali, 

    15:10

    Open Discussion/ QA Session

    15:15

    Significance of Implementing QbD in Analytical Method Development – A Case StudyOverview

    Trupti Tol,  Associate Director,  Cipla Ltd, 

    15:30

    Open Discussion/ QA Session

    15:40

    Analytical Procedure Lifecycle

    Bhaskar Kolte,  Associate Director -ARD,  Perrigo Laboratories India Pvt Ltd, 

    15:55

    Open Discussion/ QA Session

    16:05

    Reference Standard Qualification

    Chait Wannere,  Senior Director, Analytical Development,  TCG GreenChem,  USA

    16:20

    Open Discussion/ QA Session

    16:35

    AMQ, AMV, APT Studies for Analytical Platform Technology (APT) Methods

    Stephan O. Krause,  Head of Product Quality Group,  AstraZeneca Biologics,  USA

    17:00

    Open Discussion/ QA Session

    17:15

    Rap Session

    17:30

    Closing Remarks (Prof Saranjit Singh)

    17:35

    Vote of Thanks (Dr Sanjay Bajaj)

    Details

    Registrations for this conference is closed now.

    Registration

    Registration categories will be published here.

    Menu

    • Home
    • About Us
    • Company Profile
    • Contact Us

    Contact Us

    Unit 21, Level 2, Berkeley Square, Plot No 24, Industrial & Business Park, Phase I, Chandigarh 160002, India

    events@glostem.in

    +91 172 5025050, 9041725050

    • Privacy Policy
    • Terms & Conditions
    • Cancellation & Refund Policy
    © Copyright 2025 Glostem Private Limited. All rights reserved.
    Site Created & Maintained by Digilinkers